StonvexLoading…
StonvexStonvexStonvexCore line items from ALLO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-209.31M | $-166.91M | $-122.01M | $-65.19M |
Net Income | $-190.89M | $-152.08M | $-50.94M | $-59.73M |
EPS (Diluted) | $-0.87 | $-0.70 | $-0.51 | $-0.28 |
Total Assets | $415.90M | $439.77M | $470.59M | $507.98M |
Total Liabilities | $123.36M | $124.44M | $126.03M | $122.59M |
Cash & Equivalents | $51.69M | $37.81M | $52.33M | $42.45M |
Free Cash Flow OCF − CapEx | $-149.63M | $-122.03M | $-92.10M | $-53.03M |
Shares Outstanding | 229.41M | 223.16M | 220.13M | 218.60M |